|
|
Volumn 235, Issue 2, 2002, Pages
|
|
Decision analysis for the cost-effective management of recurrent colorectal cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIAGNOSTIC AGENT;
FLUORODEOXYGLUCOSE F 18;
RADIOPHARMACEUTICAL AGENT;
CANCER STAGING;
COLORECTAL TUMOR;
COMPUTER ASSISTED EMISSION TOMOGRAPHY;
COST BENEFIT ANALYSIS;
DECISION SUPPORT SYSTEM;
ECONOMICS;
HUMAN;
LETTER;
MORTALITY;
SCINTISCANNING;
TUMOR RECURRENCE;
COLORECTAL NEOPLASMS;
COST-BENEFIT ANALYSIS;
DECISION SUPPORT TECHNIQUES;
FLUORODEOXYGLUCOSE F18;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
RADIOPHARMACEUTICALS;
TOMOGRAPHY, EMISSION-COMPUTED;
|
|
EID: 19044394141
PISSN: 00034932
EISSN: None
Source Type: Journal
DOI: 10.1097/00000658-200202000-00023 Document Type: Letter |
|
Times cited : (8)
|
|
References (0)
|
